Print

Novo Nordisk A/S (NVO) Pleased With Obesity Trial Results  
3/18/2013 6:49:27 AM

BAGSVAERD, DENMARK--(Marketwire - March 18, 2013) -


Company announcement No 19 / 2013:

http://hugin.info/2013/R/1685937/552525.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1685937]


Further information
Media:
Katrine Sperling
+45 3079 6718
Email Contact

Ken Inchausti
+1 609 786 8316
Email Contact

Ambre Morley
+1 609 987 5898
Email Contact

Investors:
Kasper Roseeuw Poulsen
+45 4442 4303
Email Contact

Frank Daniel Mersebach
+45 4442 0604
Email Contact

Lars Borup Jacobsen
+45 3075 3479
Email Contact

Jannick Lindegaard (US)
+1 609 786 4575
Email Contact